Allurion Technologies (ALUR) Net Income towards Common Stockholders (2022 - 2026)
Allurion Technologies posted quarterly Net Income towards Common Stockholders of -$6.1 million for Q1 2026, down 182.6% year-on-year from $7.4 million in Q1 2025, and down 126.48% on a QoQ basis from $23.0 million in Q4 2025.
Allurion Technologies (ALUR) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$6.1 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 182.6% year-over-year to -$6.1 million; the trailing twelve-month figure through Mar 2026 stood at -$4.3 million (down 136.58% YoY), and the FY2025 full-year result was $347000.0, up 104.82% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$6.1 million, down from $23.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $23.0 million in Q4 2025 and bottomed at -$22.7 million in Q2 2023.
- The 5-year median for Net Income towards Common Stockholders is -$9.5 million (2024), against an average of -$7.6 million.
- The widest annual swing landed in 2023, when Net Income towards Common Stockholders tumbled 270.65%; it then surged 339.59% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$13.1 million in 2022, then plunged by 63.53% to -$21.4 million in 2023, then soared by 55.08% to -$9.6 million in 2024, then surged by 339.59% to $23.0 million in 2025, then slumped by 126.48% to -$6.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$6.1 million (Q1 2026), $23.0 million (Q4 2025), and -$11.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | -6.48 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -9.34 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | -9.61 Mn |
| Sep 30, 2024 | 8.74 Mn |
| Jun 30, 2024 | -8.32 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -21.89 Mn |
| Jun 30, 2023 | -22.72 Mn |
| Mar 31, 2023 | -18.52 Mn |
| Dec 31, 2022 | -13.08 Mn |
| Sep 30, 2022 | -14.31 Mn |
| Jun 30, 2022 | -6.13 Mn |